XClose

Institute of Healthy Ageing

Home
Menu

Dr Kerri Kinghorn

Dr Kerri Kinghorn

Appointments

  • UCL Excellence Fellowship
    Genetics, Evolution & Environment
    Div of Biosciences

Joined UCL

2017-10-11

Award year Qualification Institution
2017 CCST
Certificate of Completion of Specialist Training
Neurology
Royal College of Physicians
2008 MRCP
Member of the Royal College of Physicians
Medicine
Royal College of Physicians
2006 PhD
Doctor of Philosophy
Neuroscience
University of Cambridge
2005 MB BChir
Bachelor of Medicine/ Bachelor of Surgery
Medicine/Surgery
University of Cambridge
2004 MA
Master of Arts
Medical Science
University of Cambridge
2000 BA
Bachelor of Arts
Neuroscience
University of Cambridge

Dr Kerri Kinghorn completed the MB/PhD programme at the University of Cambridge, graduating with a 1st class BA degree in Neuroscience in 2000 and a distinction in her medical degree in 2005. She gained her PhD in 2006 at the Cambridge Institute for Medical Research under the supervision of Professor David Lomas.  While completing her higher clinical training in Neurology in London, she was awarded a Wellcome Trust Post-Doctoral Clinician Scientist Fellowship. This was performed under the supervision of Professor John Hardy and Professor Dame Linda Partridge at University College London (UCL). As part of her neurology training she spent one year in Melbourne Australia as an Association of British Neurologists Australasian Fellow. Dr Kinghorn then took up a post as an Academic Clinical Lecturer in Neurology at Kings College London and completed her neurology training in 2017.


Dr Kinghorn returned to UCL in 2017 as a Rosetrees UCL Excellence Fellow and is a consultant neurologist. Dr Kinghorn's research group seeks to understand the underlying pathogenic mechanisms of neurodegenerative disorders, such as Parkinson’s and Alzheimer’s diseases, using the fruit fly Drosophila melanogaster, as well as neuronal models of disease. In particular, her research is focused on unravelling the intracellular trafficking defects in endosomal-lysosomal pathways in Parkinson’s disease.


Keywords

Alzheimer's disease|*|Drosophila|*|Neurodegneration|*|Parkinson's disease